Showing results (11-20 of 34) with videos related to
Sort By:
Pageof 4
Artificial Cells, Nanomedicine, and Biotechnology|October 31, 2017
Novel therapeutic modalities and drug delivery - erlotinib liposomes modified with galactosylated lipid: in vitro and in vivo investigationsHaoping Xu, Changyu He, Ying Liu, et al.Nuclear Medicine and Biology|May 3, 2011
Feasibility of a novel positive feedback effect of 131I-promoted Bac-Egr1-hNIS expression in malignant glioma via baculovirusRui Guo, Lipeng Tian, Bing Han, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2009
The Role of 18F-FDG PET/CT in the evaluation of Ascites of Undetermined OriginMiao Zhang, Xufeng Jiang, Min Zhang, et al.Oncology Letters|August 7, 2012
Evaluation of biodistribution and antitumor effects of (188)Re-rhk5 in a mouse model of lung cancerRui Guo, Sheng Liang, Yufei Ma, et al.The British Journal of Radiology|June 28, 2018
The use of new delineation tool "MIRADA" at the level of regional lymph nodes, step-by-step development and first results for early-stage breast cancer patientsHaoPing Xu, Alexandre Arsene Henry, Magalie Robillard, et al.Nuclear Medicine Communications|August 5, 2010
Sodium butyrate enhances the expression of baculovirus-mediated sodium/iodide symporter gene in A549 lung adenocarcinoma cellsRui Guo, Yifan Zhang, Sheng Liang, et al.Endocrine|October 7, 2009
The role of integrated (18)F-FDG PET/CT in identification of ectopic ACTH secretion tumorsHaoping Xu, Min Zhang, Ge Zhai, et al.Radiation Oncology (London, England)|November 23, 2019
Infiltration tendency of internal mammary lymph nodes involvement in patients with breast cancer: anatomical characteristics and implications for target delineationYujie Wang, Weixiang Qi, Haoping Xu, et al.Physics and Imaging in Radiation Oncology|October 13, 2025
Leveraging dixon-based magnetic resonance imaging for pelvic bone marrow imaging in radiotherapyChuyan Wang, Haoping Xu, Zhenkui Wang, et al.BMC Cancer|December 27, 2022
IMNI PRECISION trial protocol: a phase II, open-label, non-inferior randomized controlled trial of tailoring omission of internal mammary node irradiation for early-stage breast cancerWei-Xiang Qi, Lu Cao, Siyue Zheng, et al.Pageof 4